Continuous Inhibition of Epidermal Growth Factor Receptor Phosphorylation by Erlotinib Enhances Antitumor Activity of Chemotherapy in Erlotinib-Resistant Tumor Xenografts

Oncology Reports - Greece
doi 10.3892/or.2011.1614
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications


Related search